Showing results (421-430 of 651) with videos related to
Sort By:
Pageof 66
Journal of the American College of Cardiology|May 20, 2021
Finerenone Reduces New-Onset Atrial Fibrillation in Patients With Chronic Kidney Disease and Type 2 DiabetesGerasimos Filippatos, George L Bakris, Bertram Pitt, et al.Diabetes, Obesity & Metabolism|October 29, 2024
Effect of spironolactone wash-out on albuminuria after long-term treatment in individuals with type 2 diabetes and high risk of kidney disease-An observational follow-up of the PRIORITY studyVictor Wasehuus, Viktor Rotbain Curovic, Nete Tofte, et al.Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy|June 24, 2024
New Diabetic Treatment by Alleviation of Autonomic Nervous System Dysfunction Measured as Periosteal Pressure Sensitivity at Sternum Improves Empowerment, Treatment Satisfaction, and Self-Reported Health of People with Type 2 Diabetes: A Randomized TrialSofie Korsgaard Hecquet, Søren Ballegaard, Ebbe Eldrup, et al.Cardiovascular Diabetology|July 19, 2022
Circulating metabolites and molecular lipid species are associated with future cardiovascular morbidity and mortality in type 1 diabetesLuis F Ferreira-Divino, Tommi Suvitaival, Viktor Rotbain Curovic, et al.Diabetic Medicine : a Journal of the British Diabetic Association|June 20, 2026
Extracellular matrix proteins as risk markers for complications in type 1 diabetesMarte Opseth Rygg, Alexandra Louise Møller, Viktor Rotbain Curovic, et al.Diabetes, Obesity & Metabolism|December 9, 2022
Reduction of cardiac adipose tissue volume with short-term empagliflozin treatment in patients with type 2 diabetes: A substudy from the SIMPLE randomized clinical trialNiels H Brandt-Jacobsen, Mikkel Jürgens, Philip Hasbak, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|February 8, 2020
Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trialHiddo J L Heerspink, Bergur V Stefansson, Glenn M Chertow, et al.Journal of the American Heart Association|April 29, 2023
Effects of Dapagliflozin in Chronic Kidney Disease, With and Without Other Cardiovascular Medications: DAPA-CKD TrialGlenn M Chertow, Ricardo Correa-Rotter, Priya Vart, et al.Diabetes & Vascular Disease Research|May 22, 2016
Abnormal echocardiography in patients with type 2 diabetes and relation to symptoms and clinical characteristicsPeter Godsk Jørgensen, Magnus T Jensen, Rasmus Mogelvang, et al.Frontiers in Nutrition|February 27, 2023
Oral ketone esters acutely improve myocardial contractility in post-hospitalized COVID-19 patients: A randomized placebo-controlled double-blind crossover studyHelena Zander Wodschow, Filip Søskov Davidovski, Jacob Christensen, et al.Pageof 66